Radius Health Provides Business Update on Bone Health
Exclusive extension of research discovery collaboration with Mass General Hospital (MGH) Focus of the program:…
Month: March 2022
Clearmind Medicine, SciSparc Launch a Psychedelic Pharma Collaboration
The companies have begun the Collaboration with a joint pre-clinical study and are expecting its…
Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial Results
MINNEAPOLIS, March 08, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical…
BrightInsight and UCB Partner to Build Digital Care Solutions for Rare Diseases
UCB’s Digital Care Solutions for Myasthenia Gravis to be Built on the BrightInsight Platform SAN…
Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY,…
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
BioNTech and Regeneron plan to jointly conduct clinical trials evaluating FixVac candidate BNT116 in combination…
Sanofi recognized by S&P as one of the most sustainability-committed companies
Sanofi recognized by S&P as one of the most sustainability-committed companies Paris, March 8, 2022….
Achilles Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
LONDON, March 08, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
Catalyst Pharmaceuticals Named Among Forbes 2022 America’s Best Small Companies
The Company Ranked 65th of More Than 1,000 Companies Assessed CORAL GABLES, Fla., March 08,…
Monopar to Present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference
WILMETTE, Ill., March 08, 2022 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
GelStat Provides Corporate Update on Capital Restructuring
STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) — GelStat Corporation (“GelStat” or the “Company”) (OTCPink:…
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time
RALEIGH, N.C., March 08, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an…
Achieve Life Sciences Announces Participation in March Investor Conferences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences,…
VBL Therapeutics Announces Completion of Enrollment in OVAL Phase 3 Registration-Enabling Trial of Ofra-Vec in Ovarian Cancer and Unanimous Recommendation by Independent Data Safety Monitoring Committee to Continue Study as Planned
Phase 3 OVAL trial enrolled 409 patients globally at centers in the United States, Europe,…
X4 Pharmaceuticals to Announce Fourth Quarter 2021 Financial Results and Host a Conference Call and Webcast on March 17, 2022
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
Recce Pharmaceuticals Announces Safety Committee Clears Next Dose in Phase I Study of RECCE® 327
Highlights: Independent Safety Committee unanimously recommends cohort four (RECCE® 327 at 1,000mg) to commence; a…
Ocuphire Completes Enrollment in MIRA-4 Pediatric Safety Trial Evaluating Nyxol® for Reversal of Mydriasis
With Growing Rate of Childhood Myopia, MIRA-4 Trial Supports a Potential Broader RM Label for…
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surgery
MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company…
Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare
— Expands Commercial Coverage to 118 million lives and Medicare Coverage to 7.1 million lives…